Headland Strategy Group

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Headland Strategy Group provides management consulting services for biopharma, diagnostics, digital health, and medical device firms. Notable clients include Genentech/Roche, Denali, Gilead, NGM Bio, and Recursion. Headland’s value proposition is that they offer: 1, a hybrid strategy model (Commercial Strategy, BD/M&A/Partnering, and R&D/Portfolio Strategy); 2, deep expertise across diseases and technologies; 3, a flexible, results-oriented service that pairs well with fast-moving client teams; and 4, strong exposure to the US and Japan/S. Korea with offices and clients in the US and Japan.

We are seeking potential partners/customers (commercial and clinical-stage) for Alfresa Group, Japan's #1 healthcare wholesaler by market share.
Alfresa offers a range of services and funding mechanisms. Also, we are looking for additional customers for our growing US/EU-to-Japan/S. Korea partnering practice.
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
Not Provided
Development Phase of Primary Product:
Not Provided
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO and President
Headland Strategy Group